Ignite Creation Date:
2024-05-06 @ 10:35 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03303339
Status:
COMPLETED
Last Update Posted:
2023-02-27
First Post:
2017-09-06
Brief Title:
Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia AML
Sponsor:
Cardiff Oncology
Organization:
Cardiff Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-06
First Submit QC Date:
October 2 2017
Study First Post Date:
2017-10-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-31
Last Update Post Date:
2023-02-27
Last Update Post Date Type:
ACTUAL